Friday, 11 February 2011

Nafarelin




In some countries, this medicine may only be approved for veterinary use.


In the US, Nafarelin (nafarelin systemic) is a member of the drug class gonadotropin releasing hormones and is used to treat Endometriosis and Precocious Puberty.

US matches:

  • Nafarelin

  • Nafarelin nasal

  • Nafarelin Acetate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01CA02

CAS registry number (Chemical Abstracts Service)

0076932-56-4

Chemical Formula

C66-H83-N17-O13

Molecular Weight

1322

Therapeutic Category

Gonadotropin releasing hormone (GnRH) agonist

Chemical Name

5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide

Foreign Names

  • Nafarelinum (Latin)
  • Nafarelin (German)
  • Nafaréline (French)
  • Nafarelina (Spanish)

Generic Names

  • Nafarelin (OS: BAN)
  • Nafaréline (OS: DCF)
  • Nafarelin Acetate (OS: USAN, BANM)
  • RS-94991-298 (IS)

Brand Names

  • Gonazon (veterinary use)
    Intervet, Netherlands


  • Nafarelil
    Fuji Yakuhin, Japan


  • Nasanyl
    Pfizer, Japan


  • Nasarel
    Dabur, India


  • Synarel
    ARIS, Turkey; Continental, Luxembourg; Pfizer, United Arab Emirates; Pfizer, Australia; Pfizer, Bahrain; Pfizer, Brazil; Pfizer, Canada; Pfizer, Cyprus; Pfizer, Czech Republic; Pfizer, Egypt; Pfizer, Spain; Pfizer, France; Pfizer, United Kingdom; Pfizer, Ghana; Pfizer, Ireland; Pfizer, Israel; Pfizer, Netherlands; Pfizer, Saudi Arabia; Pharmacia, Bulgaria; Searle, United States


  • Synarela
    Pfizer, Germany; Pfizer, Denmark; Pfizer, Finland; Pfizer, Iceland; Pfizer, Norway; Pfizer, Sweden


  • Synrelina
    Pfizer, Switzerland

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment